Skip to main content

Research Repository

Advanced Search

Abstract LB-241: Silencing of microRNA-31 prevents esophageal neoplasia in zinc deficient rats.

Taccioli, Cristian; Chen, Hongping; Garofalo, Michela; Jiang, Yubao; Di Leva, Gianpiero; Alder, Hansjuerg; Middleton, Justin; Smalley, Karl J.; Bottoni, Arianna; Costinean, Stefan; Farber, John L.; Croce, Carlo M.; Fong, Louise Y Y

Authors

Cristian Taccioli

Hongping Chen

Michela Garofalo

Yubao Jiang

Hansjuerg Alder

Justin Middleton

Karl J. Smalley

Arianna Bottoni

Stefan Costinean

John L. Farber

Carlo M. Croce

Louise Y Y Fong



Abstract

Dietary zinc deficiency (ZD) is implicated in the pathogenesis of human esophageal squamous cell carcinoma (ESCC). microRNA-31 (miR-31) is overexpressed in human ESCC. In the rat a ZD diet promotes esophageal carcinogenesis by inducing cellular proliferation and changes in the expression of microRNA and mRNA, including overexpression of miR-31 and cancer-related proinflammation genes. Here we report that treatment of ZD rats with locked nucleic acid (LNA)-modified inhibitor of miR-31 (LNA-antimiR) prevents the development of a precancerous esophageal phenotype. Weanling rats were fed ZD or zinc-sufficient (ZS) diet for 5 weeks. Simultaneously, ZD rats were administered intravenously (twice a week) LNA-antimiR, LNA-scramble miR-31 or the vehicle saline. ZS rats received saline. Compared to ZS rats, LNA-scramble miR-31-treated or saline-treated ZD rats overexpressed miR-31 and displayed a highly proliferative and inflammatory esophageal phenotype. Treatment of ZD rats with LNA-antimiR reduced miR-31 expression in esophageal epithelia and circulating blood by ~60% and reversed the ZD-induced esophageal pathology, as evidenced by a thinned esophageal epithelium with reduced cell proliferation by PCNA immunohistochemistry and increased apoptosis by caspase-3/7 activity. Transcriptome analyses of esophageal epithelia demonstrated derepression of target mRNAs with miR-31 seed sites. In particular, Stk40 (a negative regulator of NF-κ? signaling) was demonstrated to be a bona fide miR-31 target. Using in situ hybridization and immunohistochemistry, miR-31 overexpression in ZD esophageal sections correlated with downregulation of STK40 protein, as well as with upregulation of an NF-κ? p65 - RAGE-S100A9 inflammatory pathway that in turn, was normalized by miR-31 silencing. Thus, silencing miR-31 prevents esophageal neoplasia. Overexpression of miR-31 promotes ESCC initiation by enhancing inflammation via STK40 - NF-κ? signaling. The data indicate that miR-31 may be a promising therapeutic target for improved ESCC diagnosis and prevention. Funding: National Institutes of Health grants U01 CA152758 to CMC and R01CA118560 & R21CA152505 to LYYF.

Citation

Taccioli, C., Chen, H., Garofalo, M., Jiang, Y., Di Leva, G., Alder, H., Middleton, J., Smalley, K. J., Bottoni, A., Costinean, S., Farber, J. L., Croce, C. M., & Fong, L. Y. Y. Abstract LB-241: Silencing of microRNA-31 prevents esophageal neoplasia in zinc deficient rats. Presented at AACR 104th Annual Meeting 2013; Apr 6-10, 2013, Washington, DC, USA

Presentation Conference Type Conference Paper (published)
Conference Name AACR 104th Annual Meeting 2013; Apr 6-10, 2013
Publication Date Apr 15, 2013
Deposit Date Jun 12, 2023
Journal Cancer Research
Print ISSN 0008-5472
Electronic ISSN 1538-7445
Publisher American Association for Cancer Research
Peer Reviewed Peer Reviewed
Volume 73
Issue 8_Supplement
Article Number LB-241
Pages LB-241-LB-241
DOI https://doi.org/10.1158/1538-7445.am2013-lb-241
Keywords Cancer Research; Oncology
Public URL https://keele-repository.worktribe.com/output/447005